|
7-溴苯并[c] [1,2,5]噻二唑-4-甲醛
|
B290473-5g
|
≥98% |
1071224-34-4 |
5g
|
¥ 1038.9
|
现货 |
|
0 |
阿拉丁 |
|
7-溴苯并[c] [1,2,5]噻二唑-4-甲醛
|
B290473-25g
|
≥98% |
1071224-34-4 |
25g
|
¥ 4906.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
7-溴苯并[c] [1,2,5]噻二唑-4-甲醛
|
B290473-250mg
|
≥98% |
1071224-34-4 |
250mg
|
¥ 87.9
|
现货 |
|
0 |
阿拉丁 |
|
2-溴-9,9-二对甲苯-9H-芴
|
B290374-5g
|
≥98%(HPLC) |
474918-33-7 |
5g
|
¥ 384.9
|
现货 |
|
0 |
阿拉丁 |
|
2-溴-9,9-二对甲苯-9H-芴
|
B290374-250mg
|
≥98%(HPLC) |
474918-33-7 |
250mg
|
¥ 34.9
|
现货 |
|
0 |
阿拉丁 |
|
2-溴-9,9-二对甲苯-9H-芴
|
B290374-1g
|
≥98%(HPLC) |
474918-33-7 |
1g
|
¥ 96.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 73954,双组蛋白脱乙酰基酶(HDAC)6/8抑制剂
|
B288273-5mg
|
≥98%(HPLC) |
1440209-96-0 |
5mg
|
¥ 493.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 73954,双组蛋白脱乙酰基酶(HDAC)6/8抑制剂
|
B288273-25mg
|
≥98%(HPLC) |
1440209-96-0 |
25mg
|
¥ 1090.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 73954,双组蛋白脱乙酰基酶(HDAC)6/8抑制剂
|
B288273-100mg
|
≥98%(HPLC) |
1440209-96-0 |
100mg
|
¥ 2791.9
|
现货 |
|
0 |
阿拉丁 |
|
BX 430,P2X4变构拮抗剂
|
B288181-5mg
|
Moligand™, ≥98% |
688309-70-8 |
5mg
|
¥ 426.9
|
现货 |
|
0 |
阿拉丁 |
|
BX 430,P2X4变构拮抗剂
|
B288181-25mg
|
Moligand™, ≥98% |
688309-70-8 |
25mg
|
¥ 1235.9
|
现货 |
|
0 |
阿拉丁 |
|
BX 430,P2X4变构拮抗剂
|
B288181-100mg
|
Moligand™, ≥98% |
688309-70-8 |
100mg
|
¥ 2975.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-50mg
|
≥98%(HPLC) |
1227158-85-1 |
50mg
|
¥ 4170.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-10mg
|
≥98%(HPLC) |
1227158-85-1 |
10mg
|
¥ 1037.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-100mg
|
≥98%(HPLC) |
1227158-85-1 |
100mg
|
¥ 8239.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 876,GLUT1抑制剂
|
B287376-50mg
|
≥98%(HPLC) |
1799753-84-6 |
50mg
|
¥ 4299.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 876,GLUT1抑制剂
|
B287376-10mg
|
≥98%(HPLC) |
1799753-84-6 |
10mg
|
¥ 1668.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 876,GLUT1抑制剂
|
B287376-100mg
|
≥98%(HPLC) |
1799753-84-6 |
100mg
|
¥ 6499.9
|
现货 |
|
0 |
阿拉丁 |
|
BAM 15,线粒体质子解偶联剂
|
B287299-5mg
|
≥98%(HPLC) |
210302-17-3 |
5mg
|
¥ 579.9
|
现货 |
|
0 |
阿拉丁 |
|
BAM 15,线粒体质子解偶联剂
|
B287299-25mg
|
≥98%(HPLC) |
210302-17-3 |
25mg
|
¥ 1708.9
|
现货 |
|
0 |
阿拉丁 |
|
BAM 15,线粒体质子解偶联剂
|
B287299-100mg
|
≥98%(HPLC) |
210302-17-3 |
100mg
|
¥ 4599.9
|
现货 |
|
0 |
阿拉丁 |
|
BX 471,CCR1拮抗剂
|
B286564-5mg
|
Moligand™, ≥98%(HPLC) |
217645-70-0 |
5mg
|
¥ 156.9
|
现货 |
|
0 |
阿拉丁 |
|
BX 471,CCR1拮抗剂
|
B286564-25mg
|
Moligand™, ≥98%(HPLC) |
217645-70-0 |
25mg
|
¥ 539.9
|
现货 |
|
0 |
阿拉丁 |
|
BX 471,CCR1拮抗剂
|
B286564-100mg
|
Moligand™, ≥98%(HPLC) |
217645-70-0 |
100mg
|
¥ 1379.9
|
现货 |
|
0 |
阿拉丁 |